RegenLab and MSFpharm Strengthen Their Partnership with a Scientific Event in Belgrade

From Regeneration to Collagen Stimulation: Advanced Clinical Applications of RegenLab BCT & Cellular Matrix will take place on 27 June 2026, bringing together expert faculty, live demonstrations, and hands-on training in a structured clinical program.

ORGANISED & MANAGED BY

3

RegenLab is pleased to announce a new scientific and educational event in Belgrade, developed in partnership with MSFpharm, continuing a longstanding collaboration focused on physician education and regional market development.

From Regeneration to Collagen Stimulation:
Advanced Clinical Applications of RegenLab BCT & Cellular Matrix

The scientific session will feature leading regional clinicians:

• Dr. Marijana Tubić – collagen stimulation and tissue regeneration
• Dr. Slavica Peković – advanced dermatology applications
• Dr. Ioanna Batsialou – facial rejuvenation and skin quality
• Dr. Ivana Kalezić – regenerative gynecology
• Dr. Tamara Vujačić – hair restoration and PRP protocols

Participants will engage in small-group workshops with live patients, enabling direct interaction, individualized guidance, and protocol-based treatment planning across key indications.

The program will conclude with a Scientific Gala Dinner, offering an additional platform for clinical exchange and experience sharing.

This initiative reflects RegenLab’s commitment to evidence-based regenerative medicine and structured physician education, supported by its BCT and Cellular Matrix technology platforms.

3

Dr Tamara Vujačić

hair restoration and PRP protocols

Dr Ivana Kalezić

regenerative gynecology

Dr Marijana Tubić

collagen stimulation and tissue regeneration

Dr Ioanna Batsialou

facial rejuvenation and skin quality

Dr Slavica Peković

advanced dermatology applications

About Us

Since 2003, Regen Lab SA has specialized in designing and manufacturing high-quality medical devices for cell therapies and the preparation of autologous platelet-rich plasma (PRP) from the patient's own blood for bedside procedures.

Milestones

2003 - Foundation
2010 - RegenKit first approval in bone graft
2013 - A new state-of-theart laboratory in Lausanne
2014 - Cellular Matrix first approval
2015 - Launch of Cellular Matrix in Europe

Vision

Founded in 2003, Regen Lab has become a global reference thanks to its commitment to innovation, quality, and the effectiveness of its therapeutic solutions. Here’s how we have transformed the medical landscape over the past two decades.

RegenPRP™

RegenPRP™ is a medical treatment that uses platelet-rich plasma from the patient's own blood to enhance and tissue regeneration.

RegenPRP™ - HA

RegenPRP™ - HA combination is an innovative treatment combining platelet-rich plasma (PRP) and hyaluronic acid to improve tissue regeneration and healing.

RegenPRP™ - ATS

RegenPRP™ combined with ATS (Autologous Thrombin Serum) is an advanced approach to tissue regeneration that uses autologous thrombin-enriched platelet-rich plasma (PRP) to maximise healing effects.

RegenExtracell®

RegenExtracell is an innovative tissue regeneration treatment using an extracellular matrix enriched with platelet-rich plasma (PRP).

RegenWound

RegenWound is a fully autologous solution prepared from the patient’s own blood, with the objective of providing a standardised and reproducible approach for clinical use.

Regulatory

Manufacturers of medical devices based outside the EU must designate an Authorized Representative (EU-REP) established within the EU in order to meet the CE requirements for placing medical devices on the EU market.

Quality Management

Regen Lab Quality System Management ensures the consistency of our products quality in total GMP compliance.

Our production facility rooms atmosphere is monitored to satisfy non-pyrogenic medical devices manufacturing.

Patents

As a leader in the PRP&HA regenerative field and as an innovation-driven company, Regen Lab SA has devoted important resources since 2004 to put on the market pioneering and diversified products constituting a complete set of tools/technologies for the medical community.